Quantcast
Last updated on April 17, 2014 at 9:58 EDT

Latest Microarrays Stories

2012-11-05 20:23:28

FARMINGTON, Conn., Nov. 5, 2012 /PRNewswire-iReach/ -- Techniques such as PCR, DNA microarray, DNA sequencing, mass spectrometry and flow cytometry have driven discoveries that have changed our understanding of the world. By 2015, the combined global markets for these five areas are expected to exceed $50 billion. (Photo: http://photos.prnewswire.com/prnh/20121105/CG06410) From now until December 31, Global Information Inc (GII), in exclusive partnership with our premium research partner...

2012-11-01 11:27:22

BOSTON, Nov. 1, 2012 /PRNewswire/ -- Cartagenia, the world leader in providing genetic labs and clinicians software-based workflow support for variant assessment, lab reporting, and integration of diagnostic knowledge-bases, announced today that it has signed a license agreement for the Cartagenia BENCHlab CNV platform with CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company. Irvine, CA-based CombiMatrix is a CLIA-certified and CAP-accredited, publicly-owned commercial...

2012-11-01 07:31:07

ANN ARBOR, Mich., Nov. 1, 2012 /PRNewswire/ -- Rubicon Genomics, Inc. today announced that it has partnered with Diagenode SA to integrate Rubicon's ThruPLEX(TM) technology into Diagenode's epigenetics platforms to increase the efficiency and quality of DNA sample preparation for chromatin immunoprecipitation (ChIP) applications. The new agreement allows Diagenode to incorporate the Rubicon ThruPLEX-FD technology into its new MicroPLEX Library Preparation Kit for ChIP-seq studies requiring...

2012-10-18 15:23:23

SAN DIEGO, Oct. 18, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the California Technology Assessment Forum completed an independent evaluation of the cell-free fetal DNA technology used in the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS(TM) laboratory-developed test (LDT). CTAF recommended that the use of cell-free fetal DNA as a...

2012-10-15 07:28:31

SAN DIEGO, Oct. 15, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2012 after closing of the NASDAQ Global Market on Thursday, November 8, 2012. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm ET (2:00...

2012-10-11 07:27:23

SAN DIEGO, Oct. 11, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Bill Bowen as Senior Vice President and General Counsel. Mr. Bowen will report to Dr. Harry F. Hixson, Chairman and CEO and will be responsible for all company legal and patent activities. "With Mr. Bowen's extensive expertise in biotechnology and medical device corporate counsel, he brings the critical skills to...

2012-09-19 22:22:09

COLOGNE, Germany, and SINGAPORE, September 20, 2012 /PRNewswire/ -- 2.6 million Euro financing will accelerate development of cutting-edge technology for protein analysis AyoxxA Biosystems, an international biotechnology company, today announces it has closed a 2.6 million Euro Series A financing round. The round was led by Wellington Partners Venture Capital and included NRW.BANK, HTGF - High-Tech-Gruenderfonds, and private investors, Rainer Christine and Dr. Gregor...

2012-09-19 02:29:26

SAN DIEGO and BERLIN, Sept. 19, 2012 /PRNewswire/ -- Genalyte, Inc., a life sciences company developing and commercializing innovative next generation multiplexing technology, and Scienion AG, a life science company developing microarray and ultra-low volume liquid handling systems, today announced an agreement under which Genalyte will market Scienion's sciFLEXARRAYER(TM)( )automated liquid dispensers along with Genalyte's multiplexed Maverick(TM )Detection System. The Maverick platform...

2012-09-17 10:23:55

SAN DIEGO, Sept. 17, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced the completion of its offering of $130.0 million aggregate principal amount of 5.00% Convertible Senior Notes due 2017 (the "Convertible Notes") in a private offering, including $20.0 million aggregate principal amount of notes sold pursuant to the full exercise of an over-allotment option previously granted to the initial purchasers. Sequenom intends to use the net proceeds from this offering to fund...

2012-09-13 02:28:30

AMSTERDAM and IRVINE, Calif., Sept. 13, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, announced today that they will present five posters on genomic research studies in breast cancer at the American Society of Clinical Oncology (ASCO) 2012 Breast Cancer Symposium. The meeting will be held from September 13-15, 2012 at the Marriott Marquis in San Francisco, California. Agendia's Symphony(TM) suite of molecular...